| Name | Title | Contact Details |
|---|---|---|
Milan Vinnola |
General Counsel | Profile |
We are a clinical-stage biopharmaceutical company focused on changing the lives of patients living with nonalcoholic steatohepatitis (NASH) and other liver and metabolic disorders. Our teams in the US and Israel are developing highly differentiated medicines that address unmet medical needs based on robust research. Our lead product candidate, BIO89-100, is a novel long-acting glycopegylated fibroblast growth factor 21 (FGF21) analogue.
One Cell Systems is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nines is a dynamic team applying world-class ML and AI expertise to the field of medicine.
Infomed is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
OPK Biotech is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.